IS8222A - Tissue-protecting cell messengers to protect, restore and improve responsive cells, tissues and organs, and to have extended therapeutic capacity - Google Patents

Tissue-protecting cell messengers to protect, restore and improve responsive cells, tissues and organs, and to have extended therapeutic capacity

Info

Publication number
IS8222A
IS8222A IS8222A IS8222A IS8222A IS 8222 A IS8222 A IS 8222A IS 8222 A IS8222 A IS 8222A IS 8222 A IS8222 A IS 8222A IS 8222 A IS8222 A IS 8222A
Authority
IS
Iceland
Prior art keywords
restore
organs
tissues
tissue
protect
Prior art date
Application number
IS8222A
Other languages
Icelandic (is)
Inventor
Cerami Anthony
Brines Michael
Coleman Thomas
Original Assignee
The Kenneth S. Warren Institute, Inc.
H. Lundbeck A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Kenneth S. Warren Institute, Inc., H. Lundbeck A/S filed Critical The Kenneth S. Warren Institute, Inc.
Publication of IS8222A publication Critical patent/IS8222A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1816—Erythropoietin [EPO]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IS8222A 2004-05-20 2006-01-10 Tissue-protecting cell messengers to protect, restore and improve responsive cells, tissues and organs, and to have extended therapeutic capacity IS8222A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2004/015863 WO2005117927A2 (en) 2004-05-20 2004-05-20 Tissue protective cytokines with an extended therapeutic window

Publications (1)

Publication Number Publication Date
IS8222A true IS8222A (en) 2006-01-10

Family

ID=35463339

Family Applications (1)

Application Number Title Priority Date Filing Date
IS8222A IS8222A (en) 2004-05-20 2006-01-10 Tissue-protecting cell messengers to protect, restore and improve responsive cells, tissues and organs, and to have extended therapeutic capacity

Country Status (7)

Country Link
CN (1) CN1897960A (en)
AU (1) AU2004319797A1 (en)
BR (1) BRPI0412869A (en)
IL (1) IL172036A0 (en)
IS (1) IS8222A (en)
NO (1) NO20062506L (en)
WO (1) WO2005117927A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7718363B2 (en) 2003-04-25 2010-05-18 The Kenneth S. Warren Institute, Inc. Tissue protective cytokine receptor complex and assays for identifying tissue protective compounds
WO2019072411A1 (en) * 2017-10-10 2019-04-18 Augustinus Bader Erythropoietin (epo) application in spinal cord injury (sci) therapy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7300915B2 (en) * 2002-06-05 2007-11-27 The Regents Of The University Of California Use of erythropoietin and erythropoietin mimetics for the treatment of neuropathic pain
US20040091961A1 (en) * 2002-11-08 2004-05-13 Evans Glen A. Enhanced variants of erythropoietin and methods of use
NZ542092A (en) * 2003-03-27 2008-04-30 Janssen Pharmaceutica Nv Use of erythropoietin (EPO) in stroke recovery wherein the EPO is formulated for administration for a particular dosage regime

Also Published As

Publication number Publication date
BRPI0412869A (en) 2006-10-03
WO2005117927A3 (en) 2006-05-11
AU2004319797A1 (en) 2006-01-12
NO20062506L (en) 2006-05-31
AU2004319797A8 (en) 2008-12-11
CN1897960A (en) 2007-01-17
IL172036A0 (en) 2009-02-11
WO2005117927A2 (en) 2005-12-15

Similar Documents

Publication Publication Date Title
IS8156A (en) Tissue protective cells to protect, restore, and improve responsive cells, tissues and organs, and have extended therapeutic capacity
IS7604A (en) Transformed tissue-protective cell messengers and nucleic acids that represent them, acts to protect, repair, and improve responsive cells, tissues, and organs
IL272587B (en) Adherent cells from placenta tissues and use thereof in therapy
PL2921500T3 (en) Genetically modified human natural killer cell lines
IS8075A (en) Tissue Receptor Cell Prototype, Tests to Identify Tissue Protective Compounds and Their Use
DK1905117T3 (en) IMPROVED PERFLUORATED MEMBRANES AND IMPROVED ELECTROLYTS FOR REDOX CELLS AND BATTERIES
HRP20150220T1 (en) Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells
WO2008048620A3 (en) Gels with predetermined conductivity used in irreversible electroporation of tissue
DE112004002289D2 (en) Electrochemical battery cell
EP1885859A4 (en) Controlled electroporation and mass transfer across cell membranes in tissue
ZA200509760B (en) Composition for maintaining organ and cell viability
EP1766768A4 (en) Use of lacritin in promoting ocular cell survival
EP2210622A4 (en) Therapeutic agent for heart disease, which is intended to be used in cell transplantation therapy
BRPI0809902A2 (en) METHODS FOR ASSESSING CELLS AND CELL CROPS
DK1896571T3 (en) Materials and Methods Relating to Cell-Based Treatments
WO2006062935A3 (en) Methods of reducing the incidence of rejection in tissue transplantation through the prophylactic use of recombinant human antihrombin
DE602005022287D1 (en) LEAD BATTERY AND LEAD-BATTERY STORAGE PROCEDURE
ATE514784T1 (en) CELL PREPARATION
EP1778267A4 (en) Compositions and methods related to heart failure
IL163599A0 (en) Host cells having improved cell survival properties and methods to generate such cells
IS8222A (en) Tissue-protecting cell messengers to protect, restore and improve responsive cells, tissues and organs, and to have extended therapeutic capacity
DE602004010307D1 (en) USE OF POLYSULPATED ALGINATE IN CELL MATRIX
DK1866331T3 (en) PROCEDURE AND BODY TO DETERMINE AND ACQUIRE STRESS STOLERANCE IN PLANTS
EP1692187A4 (en) Ec sod and cell transducing ec sod and use thereof
FR2868421B1 (en) NOVEL BENZOTHIAZOLES AND THEIR USE AS MEDICAMENTS